Boguslaw Rucinski

1.7k total citations
39 papers, 1.4k citations indexed

About

Boguslaw Rucinski is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Boguslaw Rucinski has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 12 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Boguslaw Rucinski's work include Platelet Disorders and Treatments (15 papers), Protease and Inhibitor Mechanisms (5 papers) and Proteoglycans and glycosaminoglycans research (5 papers). Boguslaw Rucinski is often cited by papers focused on Platelet Disorders and Treatments (15 papers), Protease and Inhibitor Mechanisms (5 papers) and Proteoglycans and glycosaminoglycans research (5 papers). Boguslaw Rucinski collaborates with scholars based in United States, Sweden and Canada. Boguslaw Rucinski's co-authors include Stefan Niewiarowski, John Clifford Holt, Solomon Epstein, Haldon P. Bryer, Farrel J. Buchinsky, David F. Romero, Gary N. Mann, Alan M. Gewirtz, Bruno Calabretta and W.S.S. Jee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Boguslaw Rucinski

39 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boguslaw Rucinski United States 21 428 376 360 243 222 39 1.4k
Alfred J. Fish United States 26 201 0.5× 403 1.1× 181 0.5× 72 0.3× 378 1.7× 47 2.2k
DF Bainton United States 15 753 1.8× 514 1.4× 224 0.6× 203 0.8× 519 2.3× 26 2.1k
Sherry Thornton United States 26 646 1.5× 597 1.6× 175 0.5× 213 0.9× 103 0.5× 67 2.0k
G. Szegedi Hungary 25 190 0.4× 262 0.7× 129 0.4× 119 0.5× 108 0.5× 79 1.9k
Lachy McLean United States 12 213 0.5× 199 0.5× 402 1.1× 113 0.5× 35 0.2× 23 1.7k
Timothy E. Cawston United Kingdom 19 131 0.3× 341 0.9× 230 0.6× 291 1.2× 147 0.7× 27 1.3k
Mehrdad Baghestanian Austria 25 183 0.4× 358 1.0× 456 1.3× 137 0.6× 337 1.5× 44 2.0k
Kazuko Shiozawa Japan 23 138 0.3× 351 0.9× 128 0.4× 277 1.1× 164 0.7× 59 1.4k
Masanori Kawashima Japan 19 438 1.0× 636 1.7× 213 0.6× 291 1.2× 73 0.3× 38 2.0k
Jean‐Marc Massé France 18 809 1.9× 423 1.1× 123 0.3× 195 0.8× 216 1.0× 36 1.6k

Countries citing papers authored by Boguslaw Rucinski

Since Specialization
Citations

This map shows the geographic impact of Boguslaw Rucinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boguslaw Rucinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boguslaw Rucinski more than expected).

Fields of papers citing papers by Boguslaw Rucinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boguslaw Rucinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boguslaw Rucinski. The network helps show where Boguslaw Rucinski may publish in the future.

Co-authorship network of co-authors of Boguslaw Rucinski

This figure shows the co-authorship network connecting the top 25 collaborators of Boguslaw Rucinski. A scholar is included among the top collaborators of Boguslaw Rucinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boguslaw Rucinski. Boguslaw Rucinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sass, David A., Boguslaw Rucinski, Haldon P. Bryer, et al.. (1996). Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment. Bone. 19(4). 381–386. 2 indexed citations
2.
Mann, Gary N., David A. Sass, Farrel J. Buchinsky, et al.. (1996). Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporin A-induced osteopenia in the rat. Calcified Tissue International. 59(1). 38–44. 7 indexed citations
3.
Buchinsky, Farrel J., Y.F. Ma, Gary N. Mann, et al.. (1996). T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.. Endocrinology. 137(6). 2278–2285. 85 indexed citations
4.
Romero, David F., Haldon P. Bryer, Boguslaw Rucinski, et al.. (1995). Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcified Tissue International. 56(1). 54–61. 26 indexed citations
5.
Rucinski, Boguslaw, et al.. (1995). The effect of medroxyprogesterone acetate on bone metabolism in the oophorectomized, tamoxifen-treated rat.. Endocrinology. 136(2). 713–719. 7 indexed citations
6.
Bryer, Haldon P., Gary N. Mann, Boguslaw Rucinski, et al.. (1995). AzaThioprine alone is bone sparing and does not alter cyclosporin A-induced osteopenia in the rat. Journal of Bone and Mineral Research. 10(1). 132–138. 68 indexed citations
7.
Rucinski, Boguslaw, Gary N. Mann, & Sol Epstein. (1995). A new rapid and reproducible homologous immunoradiometric assay for amino-terminal parathyroid hormone in the rat. Calcified Tissue International. 56(1). 83–87. 12 indexed citations
8.
Rucinski, Boguslaw, et al.. (1994). Utilization of cyclosporine H to elucidate the possible mechanisms of cyclosporine A-induced osteopenia in the rat. Metabolism. 43(9). 1114–1118. 17 indexed citations
9.
Musial, J., Stefan Niewiarowski, Boguslaw Rucinski, et al.. (1990). Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms.. Circulation. 82(1). 261–273. 113 indexed citations
10.
Rucinski, Boguslaw, et al.. (1990). Batroxostatin, an Arg-Gly-Asp-containing peptide from Bothrops atrox, is a potent inhibitor of platelet aggregation and cell interaction with fibronectin. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1054(3). 257–262. 59 indexed citations
11.
Rucinski, Boguslaw, et al.. (1990). Elegantin and albolabrin purified peptides from viper venoms; homologies with the RGDS domain of fibrinogen and von Willebrand factor. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1039(1). 81–89. 74 indexed citations
12.
Cook, Jacquelynn J., Tur‐Fu Huang, Boguslaw Rucinski, et al.. (1989). Inhibition of platelet hemostatic plug formation by trigramin, a novel RGD-peptide. American Journal of Physiology-Heart and Circulatory Physiology. 256(4). H1038–H1043. 37 indexed citations
13.
Gewirtz, Alan M., et al.. (1989). Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide.. Journal of Clinical Investigation. 83(5). 1477–1486. 125 indexed citations
14.
Rucinski, Boguslaw, et al.. (1987). Uptake and Processing of Human Platelet Factor 4 by Hepatocytes. Experimental Biology and Medicine. 186(3). 361–367. 8 indexed citations
15.
Gewirtz, Alan M., Wei Xu, Boguslaw Rucinski, & Stefan Niewiarowski. (1987). SELECTIVE INHIBITION OF HUMAN MEGAKARYOCYTOPOIESIS IN VITRO BY HIGHLY PURIFIED PLATELET FACTOR 4. Thrombosis and Haemostasis. 1 indexed citations
16.
Cierniewski, Czesław S., Stefan Niewiarowski, Diáne Hershock, Boguslaw Rucinski, & Alvin H. Schmaier. (1987). Quantitation and characterization of human platelet glycoprotein IIIa by radioimmunoassay. Biochimica et Biophysica Acta (BBA) - General Subjects. 924(1). 216–224. 5 indexed citations
17.
Capitanio, A, Stefan Niewiarowski, Boguslaw Rucinski, et al.. (1985). Interaction of platelet factor 4 with human platelets. Biochimica et Biophysica Acta (BBA) - General Subjects. 839(2). 161–173. 67 indexed citations
18.
Switalska, Hanna I., Stefan Niewiarowski, George P. Tuszynski, et al.. (1985). Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation.. PubMed. 106(6). 690–700. 33 indexed citations
19.
Paul, D., et al.. (1980). Human platelet basic protein associated with antiheparin and mitogenic activities: purification and partial characterization.. Proceedings of the National Academy of Sciences. 77(10). 5914–5918. 26 indexed citations
20.
Rucinski, Boguslaw, et al.. (1975). Proceedings: Binding of (14C) dipyradamole (RA 8) to platelets and inhibition of ADP induced platelet aggregation.. PubMed. 34(2). 552–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfred J. Fish Breakdown of academic impact, for papers by DF Bainton Breakdown of academic impact, for papers by Sherry Thornton Breakdown of academic impact, for papers by G. Szegedi Breakdown of academic impact, for papers by Lachy McLean Breakdown of academic impact, for papers by Timothy E. Cawston Breakdown of academic impact, for papers by Mehrdad Baghestanian Breakdown of academic impact, for papers by Kazuko Shiozawa Breakdown of academic impact, for papers by Masanori Kawashima Breakdown of academic impact, for papers by Jean‐Marc Massé
Rankless by CCL
2026